Edition:
United States

BioScrip can now dispense & administer radicava treatment option for amyotrophic lateral sclerosis


Thursday, 5 Oct 2017 08:00am EDT 

Oct 5 (Reuters) - Bioscrip Inc :BioScrip says can now dispense & administer Radicava (edaravone) treatment option for amyotrophic lateral sclerosis approved by U.S. FDA.